Trinity Biotech (TRIB) Construction in Progress (2016 - 2018)

Trinity Biotech has disclosed Construction in Progress across 3 years of filings, most recently posting $204000.0 for Q4 2018.

• Construction in Progress for Q4 2018 came in at $204000.0, down 63.64% year-over-year; the trailing twelve-month figure through Dec 2018 was $204000.0 (down 63.64% YoY), and the FY2018 annual result was $204000.0, down 63.64% from the prior year.
• Construction in Progress came in at $204000.0 for Q4 2018 at Trinity Biotech, down from $561000.0 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $778000.0 in Q4 2016 to a low of $204000.0 in Q4 2018.
• The 3-year median for Construction in Progress is $561000.0 (2017), against an average of $514333.3.
• Across the five-year window, Construction in Progress retreated 27.89% in 2017 and slumped 63.64% in 2018, its largest moves.
• Trinity Biotech's Construction in Progress stood at $778000.0 in 2016, then retreated by 27.89% to $561000.0 in 2017, then plunged by 63.64% to $204000.0 in 2018.
• The last three Construction in Progress figures came in at $204000.0 (Q4 2018), $561000.0 (Q4 2017), and $778000.0 (Q4 2016), per Business Quant data.